Radiotherapy Market Size By Type (External Beam Radiation Therapy {Intensity-Modulated Radiation Therapy [IMRT], Image-Guided Radiation Therapy [IGRT], Proton Therapy}, Internal Radiation Therapy, Systemic Radiation Therapy), By Application (Lung Cancer,

Radiotherapy Market Size By Type (External Beam Radiation Therapy {Intensity-Modulated Radiation Therapy [IMRT], Image-Guided Radiation Therapy [IGRT], Proton Therapy}, Internal Radiation Therapy, Systemic Radiation Therapy), By Application (Lung Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head & Neck Cancer), By End-use (Hospitals, Radiotherapy Centers & Ambulatory Surgery Centers, Cancer Research Institutes), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022- 2030

The global radiotherapy market is expected to expand substantially through 2030, owing to the increasing awareness regarding cancer therapy across the globe.

From a competitive viewpoint, the emergence of radiotherapy has led to new businesses that are overtaking incumbent companies. The cancer rate is growing substantially across the world, so it is crucial to increase cancer awareness among people of all ages. These cancer awareness initiatives aim to spread vital healthcare information to a sizable demographic around the world. For example, The Union for International Cancer Control's (UICC) Breast Cancer Program assists in addressing people's urgent demand to advance breast cancer research.

The radiotherapy market has been segmented in terms of type, application, end-use, and region.

Based on type, the industry has been divided into internal radiation therapy (IRT), systemic radiation therapy, and external beam radiation therapy. The IRT segment accounted for around 20% market share in 2021 and is anticipated to witness astounding market expansion through the analysis timeframe.

With respect to application, the radiotherapy industry has been bifurcated into cervical cancer, head & neck cancer, and others. The cervical cancer segment held over 11.5% market share in 2021 and is set to foresee considerable growth over the review timeline attributed to the rising prevalence of cervical cancer worldwide and expanding public awareness concerning early diagnosis.

Meanwhile, the head & neck cancer segment was valued at approximately $531 million in 2021 and is slated to witness significant market expansion over the forecast period due to the growing cases of head & neck cancer across the world. The others segment registered a market share of about 13.5% in 2021 and is expected to hit a sizeable market valuation through the end of 2030.

Based on end-use, the market is classified into radiotherapy centers & ambulatory surgery centers (ASCs). The radiotherapy centers & ASCs segment is set to expand profitably as a result of technological advancements and organizations working to increase public knowledge of the radiotherapy procedure for tumor removal.

From the regional perspective, the Europe radiotherapy market held an extensive market share of over 25.5% in 2021 and is projected to register a steady growth rate over the review timeline owing to the presence of strong healthcare infrastructure as well as industry participants who are laser-focused on cancer treatment research and development (R&D).

Meanwhile, the Middle East & Africa radiotherapy industry accounted for over $395 million market size in 2021 and is estimated record significant profit in the forecast timeline. The MEA region’s growth can be credited to rising healthcare costs, supportive government policies, and rising cancer awareness.